- Home
- AORT
AORT
Artivion Inc.
as of 12-11-2025 11:04am EST
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | KENNESAW |
| Market Cap: | 2.1B | IPO Year: | 1993 |
| Target Price: | $49.36 | AVG Volume (30 days): | 355.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.97 - $48.04 | Next Earning Date: | 11-06-2025 |
| Revenue: | $422,646,000 | Revenue Growth: | 9.81% |
| Revenue Growth (this year): | 15.97% | Revenue Growth (next year): | 10.96% |
AI-Powered AORT Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Artivion Inc. (AORT)
VP, Chief Accounting Officer
Avg Cost/Share
$44.42
Shares
4,572
Total Value
$203,083.67
Owned After
130,058
SEC Form 4
SVP, General Counsel
Avg Cost/Share
$45.30
Shares
7,315
Total Value
$331,369.50
Owned After
161,360
President & CEO
Avg Cost/Share
$45.46
Shares
30,921
Total Value
$1,405,699.58
Owned After
800,993
SEC Form 4
President & CEO
Avg Cost/Share
$45.56
Shares
30,921
Total Value
$1,408,729.84
Owned After
800,993
SEC Form 4
SVP, Clinical & MD Affair
Avg Cost/Share
$45.13
Shares
47,376
Total Value
$2,133,920.12
Owned After
44,753
SVP, Clinical & MD Affair
Avg Cost/Share
$44.24
Shares
15,276
Total Value
$674,825.40
Owned After
44,753
Director
Avg Cost/Share
$45.10
Shares
4,200
Total Value
$189,411.60
Owned After
27,189
SEC Form 4
VP, Chief Accounting Officer
Avg Cost/Share
$45.73
Shares
6,000
Total Value
$274,380.00
Owned After
130,058
SEC Form 4
SVP, General Counsel
Avg Cost/Share
$45.17
Shares
6,394
Total Value
$288,816.98
Owned After
161,360
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$45.17
Shares
6,394
Total Value
$288,816.98
Owned After
198,842
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Horton Amy | AORT | VP, Chief Accounting Officer | Dec 8, 2025 | Sell | $44.42 | 4,572 | $203,083.67 | 130,058 | |
| Holloway Jean F | AORT | SVP, General Counsel | Dec 3, 2025 | Sell | $45.30 | 7,315 | $331,369.50 | 161,360 | |
| Mackin James P | AORT | President & CEO | Dec 3, 2025 | Sell | $45.46 | 30,921 | $1,405,699.58 | 800,993 | |
| Mackin James P | AORT | President & CEO | Dec 2, 2025 | Sell | $45.56 | 30,921 | $1,408,729.84 | 800,993 | |
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | Nov 21, 2025 | Sell | $45.13 | 47,376 | $2,133,920.12 | 44,753 | |
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | Nov 20, 2025 | Sell | $44.24 | 15,276 | $674,825.40 | 44,753 | |
| Hoff Elizabeth A | AORT | Director | Nov 18, 2025 | Sell | $45.10 | 4,200 | $189,411.60 | 27,189 | |
| Horton Amy | AORT | VP, Chief Accounting Officer | Nov 17, 2025 | Sell | $45.73 | 6,000 | $274,380.00 | 130,058 | |
| Holloway Jean F | AORT | SVP, General Counsel | Nov 17, 2025 | Sell | $45.17 | 6,394 | $288,816.98 | 161,360 | |
| Davis John E | AORT | Chief Commercial Officer | Nov 17, 2025 | Sell | $45.17 | 6,394 | $288,816.98 | 198,842 |
Compare AORT vs Leading Stocks
See how AORT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AORT Artivion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.